Vascular actions of an inhffiltor of substance P amidation

J. Z. Hunny, C. P. Oldham, G. Abou-Mohamed, D. Ulrich, L. M. Jin, S. W. May, Robert William Caldwell

Research output: Contribution to journalArticle

Abstract

Substance P (SP) relaxes vascular tissue by stimulating endothelial cell (EC) nitric oxide synthase. A two enzyme system [peptidylglycine α-nx>nooxygenasc(PAM) and peptidylamidoglycolate lyase (POL)] which converts glycine-extended precursors to active nmidatcd peptides, such as SP, has been discovered in EC (Oldham et al., 1992). Our aim was to determine whether a SP precursor can be processed within EC and subsequently act on the EC and the vasculature. Isolated intact rat aortic strips perfused in Krebs solution were preconstricted with phenylephrine (PE) and then exposed to graded concentrations of SP or its glycineextended precursor, SP-Gly (10-8 - 10-3 M) at 10 rain, intervals. The degree of relaxation was monitored. Both agents produced a comparable degree of vasorelaxation. In other aortas pretreated with an inhibitor of PAM, 4-phenyl-3-butenoic acid (PBA) at 10-5 M for 30 min., we also examined the ability of SP or SP-Gly to produce vasorelaxation after PE contraction. The PBA markedly reduced the vasorelaxation to SP-Gly (-80%). However, it did not alter the vasorelaxing response to SP. PBA also reduced PE contraction by -45%. In isolated bovine EC, PBA (105M) also reduced basal nitric oxide synthase activity (L-arginine to L-citrulline conversion) by -28%. We conclude that EC can process a precursor of SP to an active peptide capable of relaxing vascular muscle. Thus, locally produced SP may modulate EC and vascular function.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number3
StatePublished - Dec 1 1996

Fingerprint

Substance P
Blood Vessels
Endothelial cells
Endothelial Cells
Phenylephrine
Vasodilation
Pulse amplitude modulation
peptidylamidoglycolate lyase
Nitric Oxide Synthase
Citrulline
Peptides
Rain
Nitric Oxide Synthase Type III
Glycine
Arginine
Muscle
Aorta
Rats
Tissue
Muscles

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Hunny, J. Z., Oldham, C. P., Abou-Mohamed, G., Ulrich, D., Jin, L. M., May, S. W., & Caldwell, R. W. (1996). Vascular actions of an inhffiltor of substance P amidation. FASEB Journal, 10(3).

Vascular actions of an inhffiltor of substance P amidation. / Hunny, J. Z.; Oldham, C. P.; Abou-Mohamed, G.; Ulrich, D.; Jin, L. M.; May, S. W.; Caldwell, Robert William.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

Hunny, JZ, Oldham, CP, Abou-Mohamed, G, Ulrich, D, Jin, LM, May, SW & Caldwell, RW 1996, 'Vascular actions of an inhffiltor of substance P amidation', FASEB Journal, vol. 10, no. 3.
Hunny JZ, Oldham CP, Abou-Mohamed G, Ulrich D, Jin LM, May SW et al. Vascular actions of an inhffiltor of substance P amidation. FASEB Journal. 1996 Dec 1;10(3).
Hunny, J. Z. ; Oldham, C. P. ; Abou-Mohamed, G. ; Ulrich, D. ; Jin, L. M. ; May, S. W. ; Caldwell, Robert William. / Vascular actions of an inhffiltor of substance P amidation. In: FASEB Journal. 1996 ; Vol. 10, No. 3.
@article{04914510d0cf4e7398c0679d70ca21d7,
title = "Vascular actions of an inhffiltor of substance P amidation",
abstract = "Substance P (SP) relaxes vascular tissue by stimulating endothelial cell (EC) nitric oxide synthase. A two enzyme system [peptidylglycine α-nx>nooxygenasc(PAM) and peptidylamidoglycolate lyase (POL)] which converts glycine-extended precursors to active nmidatcd peptides, such as SP, has been discovered in EC (Oldham et al., 1992). Our aim was to determine whether a SP precursor can be processed within EC and subsequently act on the EC and the vasculature. Isolated intact rat aortic strips perfused in Krebs solution were preconstricted with phenylephrine (PE) and then exposed to graded concentrations of SP or its glycineextended precursor, SP-Gly (10-8 - 10-3 M) at 10 rain, intervals. The degree of relaxation was monitored. Both agents produced a comparable degree of vasorelaxation. In other aortas pretreated with an inhibitor of PAM, 4-phenyl-3-butenoic acid (PBA) at 10-5 M for 30 min., we also examined the ability of SP or SP-Gly to produce vasorelaxation after PE contraction. The PBA markedly reduced the vasorelaxation to SP-Gly (-80{\%}). However, it did not alter the vasorelaxing response to SP. PBA also reduced PE contraction by -45{\%}. In isolated bovine EC, PBA (105M) also reduced basal nitric oxide synthase activity (L-arginine to L-citrulline conversion) by -28{\%}. We conclude that EC can process a precursor of SP to an active peptide capable of relaxing vascular muscle. Thus, locally produced SP may modulate EC and vascular function.",
author = "Hunny, {J. Z.} and Oldham, {C. P.} and G. Abou-Mohamed and D. Ulrich and Jin, {L. M.} and May, {S. W.} and Caldwell, {Robert William}",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Vascular actions of an inhffiltor of substance P amidation

AU - Hunny, J. Z.

AU - Oldham, C. P.

AU - Abou-Mohamed, G.

AU - Ulrich, D.

AU - Jin, L. M.

AU - May, S. W.

AU - Caldwell, Robert William

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Substance P (SP) relaxes vascular tissue by stimulating endothelial cell (EC) nitric oxide synthase. A two enzyme system [peptidylglycine α-nx>nooxygenasc(PAM) and peptidylamidoglycolate lyase (POL)] which converts glycine-extended precursors to active nmidatcd peptides, such as SP, has been discovered in EC (Oldham et al., 1992). Our aim was to determine whether a SP precursor can be processed within EC and subsequently act on the EC and the vasculature. Isolated intact rat aortic strips perfused in Krebs solution were preconstricted with phenylephrine (PE) and then exposed to graded concentrations of SP or its glycineextended precursor, SP-Gly (10-8 - 10-3 M) at 10 rain, intervals. The degree of relaxation was monitored. Both agents produced a comparable degree of vasorelaxation. In other aortas pretreated with an inhibitor of PAM, 4-phenyl-3-butenoic acid (PBA) at 10-5 M for 30 min., we also examined the ability of SP or SP-Gly to produce vasorelaxation after PE contraction. The PBA markedly reduced the vasorelaxation to SP-Gly (-80%). However, it did not alter the vasorelaxing response to SP. PBA also reduced PE contraction by -45%. In isolated bovine EC, PBA (105M) also reduced basal nitric oxide synthase activity (L-arginine to L-citrulline conversion) by -28%. We conclude that EC can process a precursor of SP to an active peptide capable of relaxing vascular muscle. Thus, locally produced SP may modulate EC and vascular function.

AB - Substance P (SP) relaxes vascular tissue by stimulating endothelial cell (EC) nitric oxide synthase. A two enzyme system [peptidylglycine α-nx>nooxygenasc(PAM) and peptidylamidoglycolate lyase (POL)] which converts glycine-extended precursors to active nmidatcd peptides, such as SP, has been discovered in EC (Oldham et al., 1992). Our aim was to determine whether a SP precursor can be processed within EC and subsequently act on the EC and the vasculature. Isolated intact rat aortic strips perfused in Krebs solution were preconstricted with phenylephrine (PE) and then exposed to graded concentrations of SP or its glycineextended precursor, SP-Gly (10-8 - 10-3 M) at 10 rain, intervals. The degree of relaxation was monitored. Both agents produced a comparable degree of vasorelaxation. In other aortas pretreated with an inhibitor of PAM, 4-phenyl-3-butenoic acid (PBA) at 10-5 M for 30 min., we also examined the ability of SP or SP-Gly to produce vasorelaxation after PE contraction. The PBA markedly reduced the vasorelaxation to SP-Gly (-80%). However, it did not alter the vasorelaxing response to SP. PBA also reduced PE contraction by -45%. In isolated bovine EC, PBA (105M) also reduced basal nitric oxide synthase activity (L-arginine to L-citrulline conversion) by -28%. We conclude that EC can process a precursor of SP to an active peptide capable of relaxing vascular muscle. Thus, locally produced SP may modulate EC and vascular function.

UR - http://www.scopus.com/inward/record.url?scp=33749293131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749293131&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749293131

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -